Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

MicroRNAs as early biomarkers in obesity and related metabolic and cardiovascular diseases.

Hulsmans M, Holvoet P.

Curr Pharm Des. 2013;19(32):5704-17. Review.

PMID:
23448489
2.

Potential role of blood microRNAs as non-invasive biomarkers for early detection of asymptomatic coronary atherosclerosis in obese children with metabolic syndrome.

Omran A, Elimam D, He F, Peng J, Yin F.

Med Hypotheses. 2012 Dec;79(6):889-93. doi: 10.1016/j.mehy.2012.09.020. Epub 2012 Oct 10.

PMID:
23062773
3.

Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications.

Abate N.

J Diabetes Complications. 2000 May-Jun;14(3):154-74. Review.

PMID:
10989324
4.

Obesity and the metabolic syndrome in the elderly--a mini-review.

Lechleitner M.

Gerontology. 2008;54(5):253-9. doi: 10.1159/000161734. Epub 2008 Oct 8. Review.

5.

Small but smart--microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing.

Schroen B, Heymans S.

Cardiovasc Res. 2012 Mar 15;93(4):605-13. doi: 10.1093/cvr/cvr268. Epub 2011 Oct 11. Review.

PMID:
21994347
6.

Cardiovascular disease in childhood: the role of obesity.

Herouvi D, Karanasios E, Karayianni C, Karavanaki K.

Eur J Pediatr. 2013 Jun;172(6):721-32. doi: 10.1007/s00431-013-1932-8. Epub 2013 Jan 23. Review.

PMID:
23340698
7.

The association of obesity, metabolic syndrome, diabetes, and cardiovascular disease with nonalcoholic fatty liver disease.

Bell DS.

South Med J. 2009 Oct;102(10):991-2. doi: 10.1097/SMJ.0b013e3181b5771d. No abstract available.

PMID:
19738529
8.

Central obesity and the metabolic syndrome: implications for primary care providers.

Appel SJ, Jones ED, Kennedy-Malone L.

J Am Acad Nurse Pract. 2004 Aug;16(8):335-42. Review. Erratum in: J Am Acad Nurse Pract. 2004 Oct;16(10):425.

PMID:
15455706
9.

Role of microRNAs in obesity and the metabolic syndrome.

Heneghan HM, Miller N, Kerin MJ.

Obes Rev. 2010 May;11(5):354-61. doi: 10.1111/j.1467-789X.2009.00659.x. Epub 2009 Sep 29. Review.

PMID:
19793375
10.

Cardiovascular metabolic syndrome: mediators involved in the pathophysiology from obesity to coronary heart disease.

Roos CJ, Quax PH, Jukema JW.

Biomark Med. 2012 Feb;6(1):35-52. doi: 10.2217/bmm.11.105. Review.

PMID:
22296195
11.

Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart disease.

Rana JS, Nieuwdorp M, Jukema JW, Kastelein JJ.

Diabetes Obes Metab. 2007 May;9(3):218-32. Review.

PMID:
17391148
12.

MicroRNAs: Biomarkers for cardiovascular disease in patients with diabetes mellitus.

Briasoulis A, Tousoulis D, Vogiatzi G, Siasos G, Papageorgiou N, Oikonomou E, Genimata V, Konsola T, Stefanadis C.

Curr Top Med Chem. 2013;13(13):1533-9. Review.

PMID:
23745805
13.

Circulating microRNAs: novel biomarkers for cardiovascular diseases.

Xu J, Zhao J, Evan G, Xiao C, Cheng Y, Xiao J.

J Mol Med (Berl). 2012 Aug;90(8):865-75. doi: 10.1007/s00109-011-0840-5. Epub 2011 Dec 8. Review.

PMID:
22159451
14.

Metabolic syndrome, diabetes and cardiovascular events: current controversies and recommendations.

Zarich SW.

Minerva Cardioangiol. 2006 Apr;54(2):195-214. Review.

PMID:
16778752
15.

Lifestyle modification and endothelial function in obese subjects.

Hamdy O.

Expert Rev Cardiovasc Ther. 2005 Mar;3(2):231-41. Review.

PMID:
15853597
16.

Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.

Chapman MJ, Sposito AC.

Pharmacol Ther. 2008 Mar;117(3):354-73. doi: 10.1016/j.pharmthera.2007.10.004. Epub 2007 Dec 14. Review.

PMID:
18215759
17.

Riboregulators and metabolic disorders: getting closer towards understanding the pathogenesis of diabetes mellitus?

Tavintharan S, Chi LS, Fang SC, Arunmozhiarasi A, Jeyaseelan K.

Curr Mol Med. 2009 Apr;9(3):281-6. Review.

PMID:
19355910
18.

MR imaging evaluation of cardiovascular risk in metabolic syndrome.

van der Meer RW, Lamb HJ, Smit JW, de Roos A.

Radiology. 2012 Jul;264(1):21-37. doi: 10.1148/radiol.12110772. Review.

PMID:
22723560
19.

The metabolic syndrome: validity and utility of clinical definitions for cardiovascular disease and diabetes risk prediction.

Cameron A.

Maturitas. 2010 Feb;65(2):117-21. doi: 10.1016/j.maturitas.2009.11.026. Epub 2009 Dec 23. Review.

PMID:
20031349
20.

Clinical diagnosis of metabolic and cardiovascular risks in overweight children: early development of chronic diseases in the obese child.

l'Allemand-Jander D.

Int J Obes (Lond). 2010 Dec;34 Suppl 2:S32-6. doi: 10.1038/ijo.2010.237. Review.

PMID:
21151144

Supplemental Content

Support Center